|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 5/10 | (2006.01) |
| C12N 7/02 | (2006.01) | ||
| C12N 7/04 | (2006.01) | ||
| C12N 15/85 | (2006.01) |
| (11) | Number of the document | 3489353 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19151187.2 |
| Date of filing the European patent application | 2016-11-21 | |
| (97) | Date of publication of the European application | 2019-05-29 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201520761 | 2015-11-24 | GB | |
| 201609303 | 2016-05-26 | GB |
| (72) |
JOHNSON, Sabine , GB
PALLANT, Celeste , GB
VAMVA, Eirini , GB
VINK, Conrad , GB
|
| (73) |
GlaxoSmithKline Intellectual Property Development
Limited ,
GSK Medicines Research Centre
Gunnels Wood Road, Stevenage SG1 2NY,
GB
|
| (54) | STABLE CELL LINES FOR RETROVIRAL PRODUCTION |
| STABLE CELL LINES FOR RETROVIRAL PRODUCTION |